{"id":"W2083901189","doi":"10.12703/p6-93","title":"Expanding use of new oral anticoagulants","year":2014,"lang":"en","type":"review","venue":"F1000Prime Reports","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Rivaroxaban; Apixaban; Dabigatran; Edoxaban; Medicine; Warfarin; Direct thrombin inhibitor; Atrial fibrillation; Vitamin K antagonist; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001781997,0.0007572543,0.001458604,0.004083245,0.0002398297,0.001120654,0.0009113064,0.001261328,0.004580347],"category_scores_gemma":[0.002201568,0.0002664058,0.0010563,0.002989263,0.0005070804,0.001887926,0.0008581966,0.001602162,0.001164482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008881104,"about_ca_system_score_gemma":0.001638811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001695793,"about_ca_topic_score_gemma":0.002081466,"domain_scores_codex":[0.9989529,0.000198812,0.0002049077,0.0001277558,0.0004569181,0.00005863698],"domain_scores_gemma":[0.9987112,0.0006443006,0.0002531011,0.0000309788,0.0002935308,0.00006689042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005006492,0.00004805233,0.0004220495,0.02310055,0.0001838484,0.0002310765,0.0001036892,0.000168516,0.0006064223,0.002610691,0.02204709,0.9504279],"study_design_scores_gemma":[0.00005232684,0.0001106947,0.002468903,0.01504251,0.0003070206,0.002834728,0.0001474511,0.0000924754,0.0003437524,0.001665096,0.9769131,0.00002206593],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001116234,0.9987774,0.00004278201,0.0003310151,0.00009483199,0.000002100509,0.000006819606,0.000003322191,0.0006300438],"genre_scores_gemma":[0.0007200858,0.9984988,0.00008768956,0.0002731393,0.0002086558,0.000003165372,0.00001247507,8.799936e-7,0.0001950632],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004580347,"threshold_uncertainty_score":0.0153228,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3105205717858217,"score_gpt":0.4524429180358406,"score_spread":0.141922346250019,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}